Preclinical CRO Market Size Worth $7.8 Billion By 2027 | CAGR: 8.3%

March 2020 | Report Format: Electronic (PDF)

The global preclinical CRO market size is expected to reach USD 7.8 billion by 2027, registering a CAGR of 8.3% over the forecast period, according to a new report by Grand View Research, Inc. The market is expected to show lucrative growth due to increasing R&D expenditure and rising outsourcing trend, which is expected to increase the demand for preclinical trials in the future. Whereas rise in number of complex drugs entering clinical trials and increasing R&D expenses are some of the factors responsible for the preclinical Contract Research Organization (CRO) growth. Increasing prices and changes in reimbursement policies are also anticipated to boost the in emerging countries such as India and China.

Increasing number of new entrants in market is anticipated to help the market to grow during the forecast period. Various companies are focusing on research and development of new drugs and therefore are outsourcing these activities to launch efficient CRO services in the market.

 To request a sample copy or view summary of this report, click the link below:

Further key findings from the report suggest:

  • Toxicology testing held the largest share in the service segment in 2019 due to increasing trend of outsourcing, especially in emerging countries

  • Bioanalysis is expected to grow with the highest CAGR of 8.8% over the forecast period

  • North America dominates the market with the largest share of 47.5% in 2019 owing to advanced healthcare infrastructure in the region

  • The Asia Pacific region is projected to witness the fastest growth during the forecast period owing to government support in development of outsourcing hubs along with availability of skilled practitioners

  • Some of the key preclinical CRO market players are Envigo Corporation, MPI research, and Eurofins Scientific.

Grand View Research has segmented the global preclinical CRO market based on services, end use, and region:

Preclinical CRO Services Outlook (Revenue, USD Million, 2016 - 2027)

  • Bioanalysis and DMPK Studies

  • Toxicology Testing

  • Others

Preclinical CRO End-use Outlook (Revenue, USD Million, 2016 - 2027)

  • Biopharmaceutical Companies

  • Government and Academic Institutes

  • Medical Device Companies

Preclinical CRO Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Spain

    • Italy

    • Netherlands

    • Belgium

    • Switzerland

    • Russia

    • Sweden

  • Asia Pacific

    • India

    • Japan

    • China

    • Australia

    • South Korea

    • Malaysia

    • Indonesia

    • Singapore

    • Philippines

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

    • Chile

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Israel

    • Egypt

Request Sample
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $6,950
Enterprise Access - $8,950

Buy Chapters or Sections

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA